Self-Monitoring and Readiness Texting Project (SMART)
| Registry | NCT03177057, acronym SMART |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, health services research |
| Enrollment | 114 (Actual) |
| Sponsor | Fox Chase Cancer Center (Other); collaborators: National Cancer Institute (NCI) |
| Conditions | Skin Carcinoma |
| Interventions | Compliance Monitoring, Health Telemonitoring, Questionnaire Administration (Behavioral, other) |
| Dates | start 2013-04-23, primary completion 2014-07-30, completion 2014-12-31, first posted 2017-06-06, last updated 2018-08-01 |
| Locations | 1 site in United States |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Skin Carcinoma All trials of Compliance Monitoring All trials of Health Telemonitoring
This pilot clinical trial studies how well Self Monitoring And Readiness Texting (SMART) project works in sun exposure and protection behaviors. Measuring how behavior tracking and individually tailored messages affect risk behaviors in patients with skin cancer may help doctors plan the best prevention plan and decrease national melanoma incidence and mortality.
PRIMARY OBJECTIVES:
I. To test the effects of a behavior tracking and individually-tailored daily text message intervention on sun protection and exposure behaviors and to see if these techniques will be most effective in conjunction or separately.
SECONDARY OBJECTIVES:
I. To examine mediators in the effects of the intervention on safe sun behaviors, based on Fishbein?s Integrative Model.
OUTLINE: Patients are randomized to 1 of 4 study arms.
ARM I (SELF-MONITORING): Patients complete tanning and sun protection usage entries daily for 14 days.
ARM II (TEXT MESSAGES): Patients receive individualized text messages based on baseline assessment of tanning motives (appearance, enjoyment, social) daily for 14 days.
ARM III (COMBINED GROUP): Patients complete tanning and sun protection usage entries and also receive individualized text messages daily for 14 days.
ARM IV (CONTROL GROUP): Patients complete study assessments.
After completion of study, patients are followed up at 2 weeks.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Arm I (self-monitoring) | Experimental | Behavioral: Compliance Monitoring; Other: Questionnaire Administration | ARM I (SELF-MONITORING): Patients complete tanning and sun protection usage entries daily for 14 days. |
| Arm II (text messages) | Experimental | Other: Health Telemonitoring; Other: Questionnaire Administration | ARM II (TEXT MESSAGES): Patients receive individualized text messages based on baseline assessment of tanning motives (appearance, enjoyment, social) daily for 14 days. |
| Arm III (self-monitoring, text messages) | Experimental | Behavioral: Compliance Monitoring; Other: Health Telemonitoring; Other: Questionnaire Administration | ARM III (COMBINED GROUP): Patients complete tanning and sun protection usage entries and also receive individualized text messages daily for 14 days. |
| Arm IV (questionnaire administration) | Sham comparator | Other: Questionnaire Administration | ARM IV (CONTROL GROUP): Patients complete study assessments. |
Sex: Female, ages: 18 Years to 29 Years
Inclusion Criteria: * Women from the Philadelphia metropolitan area who own a mobile phone and who meet criteria for at least moderate risk of skin cancer based on a brief risk assessment tool
| Facility | City | Country | Status |
|---|---|---|---|
| Fox Chase Cancer Center | Philadelphia, Pennsylvania | United States |
NIH grants: P30CA006927